[go: up one dir, main page]

DK0974111T3 - Apparat og metode til automatiseret design af proteiner - Google Patents

Apparat og metode til automatiseret design af proteiner

Info

Publication number
DK0974111T3
DK0974111T3 DK98915478T DK98915478T DK0974111T3 DK 0974111 T3 DK0974111 T3 DK 0974111T3 DK 98915478 T DK98915478 T DK 98915478T DK 98915478 T DK98915478 T DK 98915478T DK 0974111 T3 DK0974111 T3 DK 0974111T3
Authority
DK
Denmark
Prior art keywords
protein design
automated protein
automated
design
protein
Prior art date
Application number
DK98915478T
Other languages
English (en)
Inventor
Stephen Mayo
Bassil I Dahiyat
D Benjamin Gordon
Arthur Street
Original Assignee
California Inst Of Techn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Inst Of Techn filed Critical California Inst Of Techn
Application granted granted Critical
Publication of DK0974111T3 publication Critical patent/DK0974111T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/003—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98915478T 1997-04-11 1998-04-10 Apparat og metode til automatiseret design af proteiner DK0974111T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4346497P 1997-04-11 1997-04-11
US5467897P 1997-08-04 1997-08-04
US6109797P 1997-10-03 1997-10-03
PCT/US1998/007254 WO1998047089A1 (en) 1997-04-11 1998-04-10 Apparatus and method for automated protein design

Publications (1)

Publication Number Publication Date
DK0974111T3 true DK0974111T3 (da) 2003-04-22

Family

ID=27366337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98915478T DK0974111T3 (da) 1997-04-11 1998-04-10 Apparat og metode til automatiseret design af proteiner

Country Status (8)

Country Link
US (11) US6188965B1 (da)
EP (1) EP0974111B1 (da)
JP (1) JP2002510966A (da)
AU (1) AU751331B2 (da)
CA (1) CA2286262A1 (da)
DE (1) DE69810603T2 (da)
DK (1) DK0974111T3 (da)
WO (1) WO1998047089A1 (da)

Families Citing this family (193)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7047171B1 (en) * 1995-12-08 2006-05-16 Sproch Norman K Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling
US20060277017A1 (en) * 1993-11-04 2006-12-07 Sproch Norman K Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling
DK0974111T3 (da) * 1997-04-11 2003-04-22 California Inst Of Techn Apparat og metode til automatiseret design af proteiner
US6403312B1 (en) 1998-10-16 2002-06-11 Xencor Protein design automatic for protein libraries
US20020048772A1 (en) * 2000-02-10 2002-04-25 Dahiyat Bassil I. Protein design automation for protein libraries
US7315786B2 (en) * 1998-10-16 2008-01-01 Xencor Protein design automation for protein libraries
US20030049654A1 (en) * 1998-10-16 2003-03-13 Xencor Protein design automation for protein libraries
AU774334B2 (en) * 1998-10-16 2004-06-24 Xencor Protein design automation for protein libraries
US7208473B2 (en) 1999-01-06 2007-04-24 Xencor, Inc. Nucleic acids and protein variants of hG-CSF with granulopoietic activity
US6627186B1 (en) 1999-01-06 2003-09-30 Xencor Nucleic acids and protein variants of hG-CSF with granulopoietic activity
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
AU2415200A (en) * 1999-01-18 2000-08-01 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
AU3210100A (en) 1999-01-19 2000-08-01 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US20070065838A1 (en) * 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
CA2362541A1 (en) * 1999-02-11 2000-08-17 Xencor, Inc. Structure-based screening techniques for drug discovery
US6864359B1 (en) 1999-02-11 2005-03-08 Xencor Structure-based screening techniques for drug discovery
JP3892167B2 (ja) * 1999-03-19 2007-03-14 富士通株式会社 粒子集団の配置を生成する生成装置および方法
US6343257B1 (en) * 1999-04-23 2002-01-29 Peptor Ltd. Identifying pharmacophore containing combinations of scaffold molecules and substituents from a virtual library
US6514729B1 (en) * 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US6946265B1 (en) 1999-05-12 2005-09-20 Xencor, Inc. Nucleic acids and proteins with growth hormone activity
JP2002543791A (ja) * 1999-05-12 2002-12-24 ゼンコー 新規な熱安定性の親アルカリ性キシラナーゼ
US6682923B1 (en) 1999-05-12 2004-01-27 Xencor Thermostable alkaliphilic xylanase
JP2002543788A (ja) * 1999-05-12 2002-12-24 ゼンコー 生長ホルモン活性を有する新規の核酸およびタンパク質
US6334099B1 (en) * 1999-05-25 2001-12-25 Digital Gene Technologies, Inc. Methods for normalization of experimental data
WO2001016862A2 (en) * 1999-09-01 2001-03-08 California Institute Of Technology Methods and compositions utilizing a branch and terminate algorithm for protein design
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
ATE341793T1 (de) * 1999-11-03 2006-10-15 Algonomics N V Verfahren zum generieren von informationen in zusammenhang mit der molekularstruktur eines biomoleküls
AU2155401A (en) * 1999-11-03 2001-05-30 Algonomics Nv Apparatus and method for structure-based prediction of amino acid sequences
JP2003524831A (ja) * 1999-11-22 2003-08-19 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム 組み合わせ空間を探索するためのシステムおよび方法
JP3964087B2 (ja) * 1999-12-24 2007-08-22 株式会社カネカ 多重変異蛋白質アミノ酸配列の最適化解を算出する方法、装置、およびこの方法の処理を実行するプログラムを記憶する記憶媒体
US7462354B2 (en) * 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
ATE304592T1 (de) * 2000-02-10 2005-09-15 Xencor Inc Automatisierung im proteinentwurf durch proteinbibliotheken
EP1621617A1 (en) * 2000-02-10 2006-02-01 Xencor, Inc. Protein design automation for protein libraries
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7244823B2 (en) * 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7687461B2 (en) * 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7662367B2 (en) 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
CA2401683A1 (en) * 2000-03-02 2001-09-07 Xencor Design and discovery of protein based tnf-.alpha. variants for the treatment of tnf-.alpha. related disorders
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US6983233B1 (en) 2000-04-19 2006-01-03 Symyx Technologies, Inc. Combinatorial parameter space experiment design
WO2001090960A2 (en) * 2000-05-24 2001-11-29 California Institute Of Technology Methods for protein design
US6586207B2 (en) * 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
DE10028875A1 (de) * 2000-06-10 2001-12-20 Hte Gmbh Rechnergestützte Optimierung von Substanzbibliotheken
US6951927B2 (en) * 2000-07-07 2005-10-04 California Institute Of Technology Proteins with integrin-like activity
AU2001278898A1 (en) * 2000-07-10 2002-01-21 Xencor Method for disigning protein libraries with altered immunogenicity
IL137886A0 (en) 2000-08-16 2001-10-31 Univ Ramot A novel algorithm for de novo protein design
AU2001280077A1 (en) * 2000-08-16 2002-02-25 Ramot University Authority For Applied Research And Industrial Development Ltd. Method and system for predicting amino acid sequence
AU2002230784A1 (en) * 2000-11-10 2002-05-21 Xencor Novel thermostable alkaliphilic xylanase
WO2002048841A2 (en) * 2000-12-15 2002-06-20 Symyx Technologies, Inc. Methods and apparatus for designing high-dimensional combinatorial experiments
US20030036854A1 (en) * 2001-02-06 2003-02-20 The Penn State Research Foundation Apparatus and method for designing proteins and protein libraries
US7231328B2 (en) * 2001-02-06 2007-06-12 The Penn State Research Foundation Apparatus and method for designing proteins and protein libraries
US20020183937A1 (en) * 2001-02-09 2002-12-05 Stephen Mayo Method for the generation of proteins with new enzymatic function
JP2005512161A (ja) * 2001-03-12 2005-04-28 ボード オブ レジェンツ，ザ ユニバーシティー オブ テキサス システム ペプチドおよびタンパク質の立体配座アンサンブルの列挙およびリガンド親和性分析のためのコンピュータベースのストラテジー
AU2002255897A1 (en) * 2001-03-12 2002-09-24 Board Of Regents, University Of Texas System Ensemble-based strategy for the design of protein pharmaceuticals
WO2002090300A2 (en) * 2001-05-04 2002-11-14 Xencor Nucleic acids and proteins with thioredoxin reductase activity
US20030211511A1 (en) * 2001-05-04 2003-11-13 Briggs Steven P. Nucleic acids and proteins with thioredoxin reductase activity
US20030049680A1 (en) * 2001-05-24 2003-03-13 Gordon D. Benjamin Methods and compositions utilizing hybrid exact rotamer optimization algorithms for protein design
US7110525B1 (en) 2001-06-25 2006-09-19 Toby Heller Agent training sensitive call routing system
US20030022285A1 (en) * 2001-07-10 2003-01-30 Chirino Arthur J. Protein design automation for designing protein libraries with altered immunogenicity
WO2003014325A2 (en) * 2001-08-10 2003-02-20 Xencor Protein design automation for protein libraries
EP1510959A3 (en) * 2001-08-10 2006-07-26 Xencor, Inc. Protein design automation for protein libraries
CA2458919A1 (en) * 2001-08-31 2003-03-13 Optimum Power Technology, L.P. Design optimization
US6822073B2 (en) * 2001-12-20 2004-11-23 Kimberly-Clark Worldwide, Inc. Modular peptide-based reagent
US20040230380A1 (en) * 2002-01-04 2004-11-18 Xencor Novel proteins with altered immunogenicity
US7381792B2 (en) 2002-01-04 2008-06-03 Xencor, Inc. Variants of RANKL protein
US7139665B2 (en) * 2002-02-27 2006-11-21 California Institute Of Technology Computational method for designing enzymes for incorporation of non natural amino acids into proteins
US20080254027A1 (en) * 2002-03-01 2008-10-16 Bernett Matthew J Optimized CD5 antibodies and methods of using the same
US20070148171A1 (en) * 2002-09-27 2007-06-28 Xencor, Inc. Optimized anti-CD30 antibodies
US20040110226A1 (en) * 2002-03-01 2004-06-10 Xencor Antibody optimization
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
US7662925B2 (en) * 2002-03-01 2010-02-16 Xencor, Inc. Optimized Fc variants and methods for their generation
US20080260731A1 (en) * 2002-03-01 2008-10-23 Bernett Matthew J Optimized antibodies that target cd19
US7317091B2 (en) * 2002-03-01 2008-01-08 Xencor, Inc. Optimized Fc variants
US8188231B2 (en) 2002-09-27 2012-05-29 Xencor, Inc. Optimized FC variants
EP1488364B1 (en) * 2002-03-26 2008-11-05 Council of Scientific and Industrial Research Method and system to build optimal models of 3-dimensional molecular structures
AU2003220559A1 (en) * 2002-03-26 2003-10-13 Carnegie Mellon University Methods and systems for molecular modeling
WO2003087310A2 (en) * 2002-04-04 2003-10-23 California Institute Of Technology Directed protein docking algorithm
US7272545B2 (en) * 2002-05-22 2007-09-18 General Electric Company Method and apparatus for designing and locating chemical structures
WO2003100002A2 (en) * 2002-05-23 2003-12-04 Board Of Regents, The University Of Texas System Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
AU2003243761A1 (en) * 2002-07-01 2004-01-19 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Conformational sampling by self-organization
DE10233047A1 (de) * 2002-07-19 2004-02-26 Amaxa Gmbh Verfahren zur Herstellung eines künstlichen Polypeptids und nach diesem Verfahren hergestelltes künstliches Protein
US20040082783A1 (en) * 2002-08-06 2004-04-29 Schafmeister Christian E. Bis (amino acid) molecular scaffolds
US20060235208A1 (en) * 2002-09-27 2006-10-19 Xencor, Inc. Fc variants with optimized properties
ATE541857T1 (de) 2002-09-27 2012-02-15 Xencor Inc Optimierte fc-varianten und herstellungsverfahren dafür
US20040175359A1 (en) * 2002-11-12 2004-09-09 Desjarlais John Rudolph Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity
US20050221443A1 (en) * 2003-01-06 2005-10-06 Xencor, Inc. Tumor necrosis factor super family agonists
US7553930B2 (en) * 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
US20060014248A1 (en) * 2003-01-06 2006-01-19 Xencor, Inc. TNF super family members with altered immunogenicity
US20050130892A1 (en) * 2003-03-07 2005-06-16 Xencor, Inc. BAFF variants and methods thereof
DK1586059T3 (da) * 2003-01-20 2010-06-14 Cambridge Entpr Ltd Beregningsfremgangsmåde og apparat til forudsigelse af et polypeptids aggregering eller opløselighed
US20040215400A1 (en) * 2003-01-21 2004-10-28 The Trustees Of The University Of Pennsylvania Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsA
US9818136B1 (en) 2003-02-05 2017-11-14 Steven M. Hoffberg System and method for determining contingent relevance
US20040176585A1 (en) * 2003-02-27 2004-09-09 Carter Richard J. Method and system for determining optimal sequences
US8388955B2 (en) * 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
US20090010920A1 (en) 2003-03-03 2009-01-08 Xencor, Inc. Fc Variants Having Decreased Affinity for FcyRIIb
US20070275460A1 (en) * 2003-03-03 2007-11-29 Xencor.Inc. Fc Variants With Optimized Fc Receptor Binding Properties
US8084582B2 (en) 2003-03-03 2011-12-27 Xencor, Inc. Optimized anti-CD20 monoclonal antibodies having Fc variants
US7587286B2 (en) 2003-03-31 2009-09-08 Xencor, Inc. Methods for rational pegylation of proteins
US7642340B2 (en) 2003-03-31 2010-01-05 Xencor, Inc. PEGylated TNF-α variant proteins
US7610156B2 (en) * 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US9051373B2 (en) 2003-05-02 2015-06-09 Xencor, Inc. Optimized Fc variants
EP1620548A2 (en) * 2003-05-07 2006-02-01 Duke University Protein design for receptor-ligand recognition and binding
WO2005014641A2 (en) * 2003-07-09 2005-02-17 Xencor, Inc. Ciliary neurotrophic factor variants
WO2005052839A2 (en) * 2003-07-29 2005-06-09 California Institute Of Technology Systems and methods for predicting transmembrane domains in membrane proteins and mining the genome for recognizing g-protein coupled receptors
US20050136481A1 (en) * 2003-08-13 2005-06-23 Trabanino Rene J. Systems and methods for predicting the structure and function of multipass transmembrane proteins
US7765175B2 (en) * 2003-09-18 2010-07-27 Optimum Power Technology, L.P. Optimization expert system
US20050065879A1 (en) * 2003-09-18 2005-03-24 Convergys Information Management Group, Inc. System and method for web service billing
US9714282B2 (en) 2003-09-26 2017-07-25 Xencor, Inc. Optimized Fc variants and methods for their generation
US8101720B2 (en) 2004-10-21 2012-01-24 Xencor, Inc. Immunoglobulin insertions, deletions and substitutions
AU2004279895A1 (en) 2003-10-10 2005-04-21 Xencor, Inc Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
WO2005038596A2 (en) * 2003-10-14 2005-04-28 Verseon Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
US20070122864A1 (en) * 2003-11-05 2007-05-31 The Regents Of The University Of California Methods for the determination of protein three-dimensional structure employing hydrogen exchange analysis to refine computational structure prediction
GB0325817D0 (en) * 2003-11-05 2003-12-10 Univ Cambridge Tech Method and apparatus for assessing polypeptide aggregation
WO2005047520A2 (en) * 2003-11-07 2005-05-26 Dna Software, Inc. System and methods for three dimensional molecular structural analysis
US7574306B1 (en) * 2003-11-20 2009-08-11 University Of Washington Method and system for optimization of polymer sequences to produce polymers with stable, 3-dimensional conformations
WO2005056759A2 (en) 2003-12-04 2005-06-23 Xencor, Inc. Methods of generating variant proteins with increased host string content and compositions thereof
US20060122783A1 (en) * 2004-08-24 2006-06-08 Ishikawa Muriel Y System and method for heightening a humoral immune response
US20070249809A1 (en) * 2003-12-08 2007-10-25 Xencor, Inc. Protein engineering with analogous contact environments
US20060003412A1 (en) * 2003-12-08 2006-01-05 Xencor, Inc. Protein engineering with analogous contact environments
US20050249723A1 (en) * 2003-12-22 2005-11-10 Xencor, Inc. Fc polypeptides with novel Fc ligand binding sites
EP2053062A1 (en) 2004-03-24 2009-04-29 Xencor, Inc. Immunoglobin variants outside the Fc region
US20050260711A1 (en) * 2004-03-30 2005-11-24 Deepshikha Datta Modulating pH-sensitive binding using non-natural amino acids
WO2005109158A2 (en) * 2004-05-05 2005-11-17 Massachusetts Institute Of Technology Methods and systems for generating peptides
US20050287639A1 (en) * 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
AU2005245910A1 (en) * 2004-05-21 2005-12-01 Xencor, Inc C1q family member proteins with altered immunogenicity
US20150010550A1 (en) 2004-07-15 2015-01-08 Xencor, Inc. OPTIMIZED Fc VARIANTS
US20060074225A1 (en) * 2004-09-14 2006-04-06 Xencor, Inc. Monomeric immunoglobulin Fc domains
WO2006044378A2 (en) * 2004-10-12 2006-04-27 University Of Iowa Research Foundation Rapid computational identification of targets
JP5227026B2 (ja) * 2004-10-28 2013-07-03 セルノ・バイオサイエンス・エルエルシー 定性的なおよび定量的な質量スペクトル分析
US20070135620A1 (en) * 2004-11-12 2007-06-14 Xencor, Inc. Fc variants with altered binding to FcRn
US8367805B2 (en) * 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
DK1817340T3 (da) * 2004-11-12 2012-08-13 Xencor Inc Fc-varianter med ændret binding til fcrn
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
WO2006076594A2 (en) * 2005-01-12 2006-07-20 Xencor, Inc. Antibodies and fc fusion proteins with altered immunogenicity
WO2006094234A1 (en) * 2005-03-03 2006-09-08 Xencor, Inc. Methods for the design of libraries of protein variants
US20080207467A1 (en) * 2005-03-03 2008-08-28 Xencor, Inc. Methods for the design of libraries of protein variants
UA97787C2 (ru) 2005-07-29 2012-03-26 Таргитед Гроут, Инк. Защита доминантным негативным мутантным krp-белком ингибирования активного циклин-cdk-комплекса krp-белком дикого типа
WO2007030594A2 (en) * 2005-09-07 2007-03-15 Board Of Regents, The University Of Texas System Methods of using and analyzing biological sequence data
US20070072226A1 (en) * 2005-09-27 2007-03-29 Indiana University Research & Technology Corporation Mining protein interaction networks
CA2624189A1 (en) * 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
AU2006302254B2 (en) 2005-10-06 2011-05-26 Xencor, Inc. Optimized anti-CD30 antibodies
US7749730B2 (en) * 2005-11-03 2010-07-06 Redpoint Bio Corporation High throughput screening assay for the TRPM5 ion channel
US7739055B2 (en) * 2005-11-17 2010-06-15 Massachusetts Institute Of Technology Methods and systems for generating and evaluating peptides
ES2504521T3 (es) 2006-03-03 2014-10-08 California Institute Of Technology Incorporación específica del sitio de aminoácidos en moléculas
US20070208411A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcated stent with surface area gradient
US20070254307A1 (en) * 2006-04-28 2007-11-01 Verseon Method for Estimation of Location of Active Sites of Biopolymers Based on Virtual Library Screening
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
US7632492B2 (en) * 2006-05-02 2009-12-15 Allozyne, Inc. Modified human interferon-β polypeptides
EP2031528A4 (en) * 2006-05-26 2009-06-17 Univ Kyoto ESTIMATING A PROTEIN-COMPOUND INTERACTION AND RATIONAL DESIGN OF A LIBRARY OF COMPOUNDS BASED ON CHEMICAL GENOMIC INFORMATION
US7674594B2 (en) * 2006-07-27 2010-03-09 Redpoint Bio Corporation Screening assay for inhibitors of TRPA1 activation by a lower alkyl phenol
ME01786B (me) 2006-08-14 2014-09-20 Xencor Inc Optimizovana antitela usmerena na cd19
AU2007299843B2 (en) 2006-09-18 2012-03-08 Xencor, Inc Optimized antibodies that target HM1.24
WO2008137471A2 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US7580304B2 (en) * 2007-06-15 2009-08-25 United Memories, Inc. Multiple bus charge sharing
CA2707840A1 (en) * 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
US7875452B2 (en) * 2007-10-01 2011-01-25 Redpoint Bio Corporation Non-desensitizing mutant of the transient receptor potential TRPM5 ion channel
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
EP2235059B1 (en) 2007-12-26 2015-02-18 Xencor, Inc. Fc variants with altered binding to fcrn
US12492253B1 (en) 2008-02-25 2025-12-09 Xencor, Inc. Anti-human C5 antibodies
US20110160071A1 (en) * 2008-06-03 2011-06-30 Baynes Brian M Novel Proteins and Methods for Designing the Same
NZ600382A (en) 2008-07-23 2013-11-29 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
WO2010080720A2 (en) 2009-01-12 2010-07-15 Nektar Therapeutics Conjugates of a lysosomal enzyme moiety and a water soluble polymer
WO2011022638A1 (en) 2009-08-20 2011-02-24 Transposagen Biopharmaceuticals, Inc. Trp inhibitors and uses thereof
US9493578B2 (en) 2009-09-02 2016-11-15 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
EP2805965A1 (en) 2009-12-21 2014-11-26 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
WO2011091078A2 (en) 2010-01-19 2011-07-28 Xencor, Inc. Antibody fc variants with enhanced complement activity
SI3572091T1 (sl) 2010-08-17 2024-07-31 Ambrx, Inc., Modificirani polipeptidi relaksina in njihova uporaba
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
JP2015500345A (ja) 2011-12-16 2015-01-05 トランスポサジェン・バイオファーマシューティカルズ・インコーポレイテッドＴｒａｎｓｐｏｓａｇｅｎ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 疼痛の治療または予防に使用されるｔｒｐｃ４調節因子
US20130252280A1 (en) * 2012-03-07 2013-09-26 Genformatic, Llc Method and apparatus for identification of biomolecules
WO2014144963A1 (en) * 2013-03-15 2014-09-18 Alexandre Zanghellini Automated method of computational enzyme identification and design
WO2014201566A1 (en) * 2013-06-21 2014-12-24 Zymeworks Inc. Systems and methods for physical parameter fitting on the basis of manual review
US10381326B2 (en) 2014-05-28 2019-08-13 Invensas Corporation Structure and method for integrated circuits packaging with increased density
EP3436470A4 (en) 2016-04-01 2019-11-20 University of Washington POLYPEPTIDES FOR THE PREPARATION OF HOMOOLIGOMERS WITH MODULAR HYDROGEN BONDING NETWORKED SPECIFICITY AND THEIR DESIGN
CN111655718B (zh) 2017-12-19 2025-07-22 Xencor股份有限公司 经过工程化的il-2 fc融合蛋白
US20190325986A1 (en) * 2018-04-24 2019-10-24 Samsung Electronics Co., Ltd. Method and device for predicting amino acid substitutions at site of interest to generate enzyme variant optimized for biochemical reaction
PL3849614T3 (pl) 2018-09-11 2024-04-22 Ambrx, Inc. Koniugaty polipeptydu interleukiny-2 i ich zastosowania
CN113366015A (zh) 2018-10-19 2021-09-07 Ambrx公司 白细胞介素-10多肽缀合物、其二聚体及其用途
AU2021233909A1 (en) 2020-03-11 2022-09-29 Ambrx, Inc. Interleukin-2 polypeptide conjugates and methods of use thereof
EP4213158A1 (en) * 2020-11-13 2023-07-19 Ahead Biocomputing, Co. Ltd Information processing device, information processing method, recording medium recording information processing program, and information processing system
US12412637B2 (en) 2021-05-11 2025-09-09 International Business Machines Corporation Embedding-based generative model for protein design
CN114495243B (zh) * 2022-04-06 2022-07-05 第六镜科技(成都)有限公司 图像识别模型训练及图像识别方法、装置、电子设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939666A (en) * 1987-09-02 1990-07-03 Genex Corporation Incremental macromolecule construction methods
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5265030A (en) * 1990-04-24 1993-11-23 Scripps Clinic And Research Foundation System and method for determining three-dimensional structures of proteins
US5241470A (en) * 1992-01-21 1993-08-31 The Board Of Trustees Of The Leland Stanford University Prediction of protein side-chain conformation by packing optimization
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5878373A (en) * 1996-12-06 1999-03-02 Regents Of The University Of California System and method for determining three-dimensional structure of protein sequences
GB9701425D0 (en) 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
DK0974111T3 (da) * 1997-04-11 2003-04-22 California Inst Of Techn Apparat og metode til automatiseret design af proteiner
US6403312B1 (en) * 1998-10-16 2002-06-11 Xencor Protein design automatic for protein libraries
US20020048772A1 (en) * 2000-02-10 2002-04-25 Dahiyat Bassil I. Protein design automation for protein libraries
US7315786B2 (en) * 1998-10-16 2008-01-01 Xencor Protein design automation for protein libraries
AU774334B2 (en) 1998-10-16 2004-06-24 Xencor Protein design automation for protein libraries
US20030049654A1 (en) * 1998-10-16 2003-03-13 Xencor Protein design automation for protein libraries
JP2002543791A (ja) 1999-05-12 2002-12-24 ゼンコー 新規な熱安定性の親アルカリ性キシラナーゼ
ATE304592T1 (de) 2000-02-10 2005-09-15 Xencor Inc Automatisierung im proteinentwurf durch proteinbibliotheken
WO2003014325A2 (en) * 2001-08-10 2003-02-20 Xencor Protein design automation for protein libraries

Also Published As

Publication number Publication date
JP2002510966A (ja) 2002-04-09
US6269312B1 (en) 2001-07-31
US20060259247A1 (en) 2006-11-16
US6950754B2 (en) 2005-09-27
US6804611B2 (en) 2004-10-12
US6801861B2 (en) 2004-10-05
EP0974111B1 (en) 2003-01-08
DE69810603T2 (de) 2003-11-13
US6188965B1 (en) 2001-02-13
EP0974111A1 (en) 2000-01-26
US6792356B2 (en) 2004-09-14
US20060019316A1 (en) 2006-01-26
US20020004706A1 (en) 2002-01-10
US20020106694A1 (en) 2002-08-08
DE69810603D1 (de) 2003-02-13
US6708120B1 (en) 2004-03-16
CA2286262A1 (en) 1998-10-22
AU751331B2 (en) 2002-08-15
WO1998047089A1 (en) 1998-10-22
US20010032052A1 (en) 2001-10-18
AU6965498A (en) 1998-11-11
US20050038610A1 (en) 2005-02-17
US20070032961A1 (en) 2007-02-08
US20010039480A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
DK0974111T3 (da) Apparat og metode til automatiseret design af proteiner
DK0881354T3 (da) Fremgangsmåde og apparat til cementering af en brønd
NO994729L (no) Fremgangsmåte og apparat til friksjonssveising
DK1005775T3 (da) Fremgangsmåde og apparat til planlægning af modsat lænkehastighed
DK1064094T3 (da) Apparat til coating af monolitiske understøtninger og fremgangsmåde herfor
DK47193D0 (da) Fremgangsmaade og apparat til fiksering af slagtesvin
DK0827696T4 (da) Fremgangsmåde og apparat til formning af et næringsmiddel
NO993498L (no) Apparat og fremgangsmÕte til innretting av rör
DK1508666T3 (da) Fremgangsmåde og apparat til fuldførelse af brønde med sidegrene
DK0762067T3 (da) Fremgangsmåde og apparat til forhindring af agglomerering
DK0956732T3 (da) Fremgangsmåde og apparat til udförelse af blöd læggen-på i et trådlöst kommunikationssytem
NO981426D0 (no) Fremgangsmåte og anordning for primær-brönn-sementering
NO994638L (no) Fremgangsmåte og apparat for ruting av kortmelding
DK1027208T3 (da) Fremgangsmåde og apparat til aktivering af en artikel
DK0770854T3 (da) Fremgangsmåde, apparat og system til bestemmelse af prøver
DK15994A (da) Fremgangsmåde og apparat til rensning af tankrum
DK0853309T3 (da) Metode og apparat til signalanalyse
NO972578D0 (no) Fremgangsmåte og anordning for forsegling
DK0923428T3 (da) Fremgangsmåde og apparat til fremstilling af slibeværktøjer
DK0958043T3 (da) Apparat og fremgangsmåde til behandling af partikelformige materialer
DK0806356T3 (da) Fremgangsmåde og apparat til de-oxygering af fødevareemballager
DK1034138T3 (da) Apparat og fremgangsmåde til rensning af vand
DK0960971T3 (da) Fremgangsmåde og apparat til foldning af beklædningsstykker
NO995567L (no) Fremgangsmåte og apparat for samvirkning
DK37497A (da) Apparat og fremgangsmåde til behandling af fotografisk materiale